Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.

We have recently shown that non-viral gene therapy can stabilise the decline of lung function in patients with cystic fibrosis (CF). However, the effect was modest, and more potent gene transfer agents are still required. Fuson protein (F)/Hemagglutinin/Neuraminidase protein (HN)-pseudotyped lentivi...

書誌詳細
主要な著者:	Alton, E, Beekman, J, Boyd, A, Brand, J, Carlon, M, Connolly, M, Chan, M, Conlon, S, Davidson, H, Davies, J, Davies, L, Dekkers, J, Doherty, A, Gea-Sorli, S, Gill, D, Griesenbach, U, Hasegawa, M, Higgins, T, Hironaka, T, Hyndman, L, McLachlan, G, Inoue, M, Hyde, S, Innes, J, Maher, T, Moran, C, Meng, C, Paul-Smith, M, Pringle, I, Pytel, K, Rodriguez-Martinez, A, Schmidt, A, Stevenson, B, Sumner-Jones, S, Toshner, R, Tsugumine, S, Wasowicz, M, Zhu, J
フォーマット:	Journal article
言語:	English
出版事項:	BMJ Publishing Group 2016

類似資料

Preparation for a first-in-man lentivirus trial in cystic fibrosis patients
著者:: Griesenbach, U, 等
出版事項: (2016)

Moving lentiviral-based gene therapy into a first-in-man CF trial
著者:: Griesenbach, D, 等
出版事項: (2015)

Towards a first-in-human trial with a pseudotyped lentivirus
著者:: Alton, EW, 等
出版事項: (2020)

Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
著者:: Hyde, S, 等
出版事項: (2015)

Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.
著者:: Griesenbach, U, 等
出版事項: (2012)

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS AS A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
著者:: Griesenbach, U, 等
出版事項: (2012)

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS IN A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
著者:: Griesenbach, U, 等
出版事項: (2012)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
著者:: Alton, E, 等
出版事項: (2014)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
著者:: Alton, E, 等
出版事項: (2014)

Lentivirus gene therapy for autoimmune pulmonary alveolar proteinosis
著者:: Palau, H, 等
出版事項: (2019)

The lung as a factory to produce secreted intrapulmonary and circulatory proteins
著者:: Paul-Smith, M, 等
出版事項: (2017)

Cumulative CFTR expression following repeated aerosol delivery of non-viral pGM169/GL67A formulation to mouse lung
著者:: Alton, E, 等
出版事項: (2012)

REPEAT ADMINISTRATION OF GL67A/PGM169 IS FEASIBLE, SAFE, AND PRODUCES ENDOGENOUS LEVELS OF CFTR EXPRESSION AFTER 12 DOSES
著者:: Alton, E, 等
出版事項: (2012)

Lentivirus GM-CSF gene therapy for autoimmune pulmonary alveolar proteinosis
著者:: Lund-Palau, H, 等
出版事項: (2018)

The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins
著者:: Paul-Smith, M, 等
出版事項: (2018)

Lentivirus GM-CSF gene therapy ameliorates autoimmune pulmonary alveolar proteinosis
著者:: Lund-Palau, H, 等
出版事項: (2018)

Recombinant Sendai virus vector to evaluate vector distribution in a large animal model of lung gene transfer
著者:: McLachlan, G, 等
出版事項: (2004)

Pre-existing immunity to human parainfluenza virus (hPIV) does not affect rSIV.F/HN-mediated transduction efficiency
著者:: Pytel, K, 等
出版事項: (2016)

Development of an immunocytochemical assay to detect human CFTR expression following gene therapy
著者:: Davidson, H, 等
出版事項: (2008)

Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung.
著者:: McLachlan, G, 等
出版事項: (2011)

TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
著者:: Griesenbach, U, 等
出版事項: (2011)

Caprine lentivirus in sheep milk and semen
著者:: C.C.V. Lima, 等

An immunocytochemical assay to detect human CFTR expression following gene transfer.
著者:: Davidson, H, 等
出版事項: (2009)

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients
著者:: Sergijenko, A, 等
出版事項: (2020)

Genetic medicines for CF: Hype versus reality
著者:: Alton, E, 等
出版事項: (2016)

A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution.
著者:: Gifford, R, 等
出版事項: (2008)

OPTIMISATION OF MOLECULAR ASSAYS FOR CLINICAL TRIAL OF GL67A/PDNA DELIVERY TO NOSE AND LUNG OF CF PATIENTS
著者:: Sumner-Jones, S, 等
出版事項: (2009)

Gene therapy for respiratory diseases; progress and a changing context
著者:: Alton, EWFW, 等
出版事項: (2020)

DEVELOPMENT, PRODUCTION AND EVALUATION OF CLINICAL GRADE CFTR EXPRESSION PLASMID FOR CF LUNG GENE THERAPY
著者:: Gill, DR, 等
出版事項: (2010)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep
著者:: Alton, E, 等
出版事項: (2013)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep.
著者:: Alton, E, 等
出版事項: (2013)

Discovery and analysis of the first endogenous lentivirus
著者:: Katzourakis, A, 等
出版事項: (2007)

Discovery and analysis of the first endogenous lentivirus.
著者:: Katzourakis, A, 等
出版事項: (2007)

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CYSTIC FIBROSIS: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY''
著者:: Davies, J, 等
出版事項: (2009)

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CF: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY"
著者:: Davies, J, 等
出版事項: (2009)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS
著者:: Davies, G, 等
出版事項: (2011)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CF
著者:: Davies, J, 等
出版事項: (2011)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis
著者:: Alton, E, 等
出版事項: (2013)

Update on the UK CF Gene Therapy Consortium Multidoes, non-viral, gene therapy trial
著者:: Alton, E, 等
出版事項: (2012)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis.
著者:: Alton, E, 等
出版事項: (2013)